VVD-133214 (Not yet branded)
Other Medications
Description
VVD-133214 is an experimental compound currently in early-phase clinical development for treatment of advanced solid tumors, including colorectal cancer. Based on available trial data, this agent is being evaluated specifically in patients with microsatellite instability-high (MSI-H) tumors as both a single agent and in combination therapy. The drug appears to be designed for tumor-agnostic treatment approaches, targeting cancers with specific biomarker characteristics rather than organ-specific indications.
Mechanism of Action
The precise molecular mechanism of action for VVD-133214 has not been publicly disclosed in available clinical trial documentation. Given its evaluation in MSI-H tumors and tumor-agnostic approach, it likely targets pathways related to DNA damage response, immune evasion, or mismatch repair deficiency that characterizes these specific tumor types.
Molecular Targets
Side Effects
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.
Clinical Trials
Quick Info
| Brand Name | Not yet branded |
| Category | Other Medications |
 Status | Experimental |
| Administration | IV |
| Clinical Trials | 1 |
Related Medications
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.